Transformative therapies with high up-front costs will exacerbate the need to address gaps between payers when costs and benefits occur at different times.
Genia Long, MPP
Advertisement
Articles by Genia Long, MPP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About the FDA's Peptide Reversal
2
Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial
3
FDA Approves First Orexin Agonist for Narcolepsy Type 1
4
Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South
5